X4 Pharmaceuticals, Inc. (XFOR) has a market capitalization of $47.91M and trades at $4.20. The 52-week range is 1.35-6.96.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.2, Earnings Per Share (EPS) of $-1.87, annual revenue of $35.11M.
The stock has a beta of 0.33, operates in the Healthcare sector.
